序号 |
标题 |
次数 |
作者 |
发布时间 |
87211 |
5-碘甲基降冰片烯 , IMNB |
128 |
kx |
2024-11-21 |
87212 |
整合素DOTA-E-[cyclo(RGDfK(Acp))]2 |
101 |
zyl |
2024-11-21 |
87213 |
DOTA-E[CYCLO(RGDFK)]2探针多肽 |
131 |
wyh |
2024-11-21 |
87214 |
DOTA-JR-11,1039726-31-2,放射显影多肽 |
122 |
zyl |
2024-11-21 |
87215 |
5-降冰片烯-2-亚甲基环氧丙基醚 , NB-MGE |
113 |
kx |
2024-11-21 |
87216 |
DO3A-Thiol ;CAS:865470-67-3 DOTA-SH |
93 |
wyh |
2024-11-21 |
87217 |
七肽DOTA-VLASSAR,CAS号:1262403-90-6 |
105 |
zyl |
2024-11-21 |
87218 |
Gd-DOTA-HCBP的组成结构 |
121 |
wyh |
2024-11-21 |
87219 |
双阳离子中心咪唑功能化降冰片烯离子液体单体 , NB-O-Im+Br--Im+Br- |
146 |
kx |
2024-11-21 |
87220 |
479081-06-6 ;DOTA-(COOt-Bu)3-NHFmoc-Lys |
116 |
wyh |
2024-11-21 |
87221 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
116 |
zyl |
2024-11-21 |
87222 |
DOTA-octreotide的组成与结构 |
106 |
wyh |
2024-11-21 |
87223 |
endo-N-3,5-双三氟甲基联苯基降冰片烯酰亚胺, endo-PTNDI |
120 |
kx |
2024-11-21 |
87224 |
DOTA-Octreotide 大环配体奥曲肽 |
131 |
zyl |
2024-11-21 |
87225 |
端丙炔基聚乙二醇(PTPEG) |
164 |
WYQ |
2024-11-21 |
87226 |
CAS:127985-74-4,DOTA-p-NCS-Bn多肽标记的双功能螯合剂 |
113 |
wyh |
2024-11-21 |
87227 |
降冰片烯-异戊二烯共聚物 ,NBE-IP |
155 |
kx |
2024-11-21 |
87228 |
cyclo(RGDFK(DOTA))的特性与功能 |
106 |
wyh |
2024-11-21 |
87229 |
DOTA-cyclo(RGDfK) |
99 |
zyl |
2024-11-21 |
87230 |
Lu-DOTA-TATE;镥-大环配体-TATE多肽 |
389 |
wyh |
2024-11-21 |
87231 |
顺-5-降冰片烯-内型-2,3-二羧酸二乙酯 , endo-NDDE |
137 |
kx |
2024-11-21 |
87232 |
DOTA-NCS,DOTA-p-NCS-Bn,cas:127985-74-4 |
110 |
zyl |
2024-11-21 |
87233 |
DOTA-PEG-CPP;大环配体DOTA-聚乙二醇-酪蛋白磷酸肽 |
115 |
wyh |
2024-11-21 |
87234 |
Gd-DOTA-COOH 钆-四氮杂环配体-羧基 |
117 |
zyl |
2024-11-21 |
87235 |
DOTA-E「cyclo(RGDfK)2 |
109 |
wyh |
2024-11-21 |
87236 |
DOTA-(Tyr3)-Octreotate;大环配体修饰多肽 |
122 |
wyh |
2024-11-21 |
87237 |
单-6-(4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑)-磺酸基-β-CD(PMA-sulfated-β-CD) |
124 |
WYQ |
2024-11-21 |
87238 |
碘丙炔基正丁氨基甲酸酯(IPBC) |
174 |
WYQ |
2024-11-21 |
87239 |
Gd-DOTA-多肽 |
96 |
zyl |
2024-11-21 |
87240 |
DSPE-PEG-DOTA ;二硬脂酰基磷脂酰乙醇胺- 聚乙二醇-大环化合物 |
309 |
wyh |
2024-11-21 |
87241 |
250612-06-7 ;DOTA-RGDfK dimer |
115 |
wyh |
2024-11-21 |
87242 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
199 |
zyl |
2024-11-21 |
87243 |
250612-06-7 DOTA多肽探针二聚体 |
91 |
wyh |
2024-11-21 |
87244 |
cas:1262403-90-6 七肽DOTA-VLASSAR |
103 |
zyl |
2024-11-21 |
87245 |
DOTA-DGln-DGln-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
99 |
wyh |
2024-11-21 |
87246 |
DOTA-NOC ;619300-53-7 |
108 |
wyh |
2024-11-21 |
87247 |
DOTA-奥曲肽,DOTA-Octreotide |
160 |
zyl |
2024-11-21 |
87248 |
DOTA-PEG5-amine ;DOTA-PEG5-NH2 |
96 |
wyh |
2024-11-21 |
87249 |
DOTA修饰肽,1180007-00-4,二肽Z-GGRDOTA |
99 |
zyl |
2024-11-21 |
87250 |
DOTA-PEG5-amine ;DOTA-PEG5-NH2 |
98 |
wyh |
2024-11-21 |
87251 |
DOTA-RGD,DOTA-cRGDfK |
156 |
zyl |
2024-11-21 |
87252 |
DOTA-Lys-Cys-Acid 二肽DOTA-Lys-Cys |
122 |
wyh |
2024-11-21 |
87253 |
DOTA-Ala-Ala-COOH ;DOTA-丙氨酸-丙氨酸-羧酸 |
135 |
wyh |
2024-11-21 |
87254 |
cas:1293368-74-7,DOTA标记的多肽 |
147 |
zyl |
2024-11-21 |
87255 |
Azido-mono-amide-DOTA ;1227407-76-2 |
86 |
wyh |
2024-11-21 |